Şahin Hatice, Şahin Murat, Bülbüloğlu Ertan, Kuş Celal, Akkök Burcu, Atilla Nurhan
Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey.
Bezmiâlem Vakıf Üniversitesi, Istanbul, Turkey.
Obes Surg. 2025 Feb;35(2):457-462. doi: 10.1007/s11695-025-07672-4. Epub 2025 Jan 8.
Obesity is one of the most important health problems in the world. It affects all systems, especially the respiratory and cardiovascular systems. Laparoscopic sleeve gastrectomy is an effective method in the treatment of obesity and can improve respiratory functions. We aimed to evaluate the effects of surgery on pulmonary function in patients with obesity.
A retrospective analysis was conducted on a group of patients who underwent sleeve gastrectomy. This study assessed pre-operative and long-term pulmonary function in patients who underwent laparoscopic sleeve gastrectomy between 2009 and 2015, with a minimum follow-up of 10 years. Patients were stratified based on smoking status and presence of comorbidities.
The study included 51 patients (82.4% female) with a mean age of 51.90 ± 11.57 years. Significant weight loss and reductions in BMI were observed postoperatively. Mean pre-operative BMI was 47.53 ± 6.95 and significantly decreased to 37.75 ± 6.02 post-operatively, BMI reduction rate was %22 (p < 0.001). Pulmonary function tests demonstrated significant improvements in FEV1 (2.65 ± 0.69 to 2.76 ± 0.67, p = 0.044), FEV1% (92.07 ± 15.31 to 97.98 ± 14.45, p = 0.001), PEF (74.01 ± 18.12 to 91.53 ± 24.16, p < 0.001), and MEF25-75 (77.17 ± 22.07 to 108.57 ± 28.11 p < 0.001) after surgery. These improvements were consistent across different subgroups, including smokers, non-smokers, and patients with and without comorbidities. Non-smokers exhibited a greater percentage increase in FEV1 compared to smokers. While there was an increase in FEV1 among patients with comorbidities, this difference was not statistically significant. Conversely, patients without comorbidities demonstrated a significant improvement in FEV1.
Bariatric surgery is associated with significant improvements in pulmonary function in obese patients, regardless of smoking status or comorbidities.
肥胖是全球最重要的健康问题之一。它影响所有系统，尤其是呼吸系统和心血管系统。腹腔镜袖状胃切除术是治疗肥胖的有效方法，且能改善呼吸功能。我们旨在评估手术对肥胖患者肺功能的影响。
对一组接受袖状胃切除术的患者进行回顾性分析。本研究评估了2009年至2015年间接受腹腔镜袖状胃切除术且随访至少10年的患者的术前和长期肺功能。患者根据吸烟状况和合并症情况进行分层。
该研究纳入了51例患者（82.4%为女性），平均年龄为51.90±11.57岁。术后观察到体重显著减轻和BMI降低。术前平均BMI为47.53±6.95，术后显著降至37.75±6.02，BMI降低率为22%（p<0.001）。肺功能测试显示术后FEV1（从2.65±0.69增至2.76±0.67，p=0.044）、FEV1%（从92.07±15.31增至97.98±14.45，p=0.001）、PEF（从74.01±18.12增至91.53±24.16，p<0.001）和MEF25 - 75（从77.17±22.07增至108.57±28.11，p<0.001）有显著改善。这些改善在不同亚组中均一致，包括吸烟者、非吸烟者以及有和无合并症的患者。与吸烟者相比，非吸烟者的FEV1百分比增加更大。虽然合并症患者的FEV1有所增加，但这种差异无统计学意义。相反，无合并症的患者FEV1有显著改善。
无论吸烟状况或合并症如何，减重手术都与肥胖患者肺功能的显著改善相关。
